Role of the PPAR-α agonist fenofibrate in severe pediatric burn. - Wikidata - awgldk - TriplyDB

Role of the PPAR-α agonist fenofibrate in severe pediatric burn.

Role of the PPAR-α agonist fenofibrate in severe pediatric burn.

http://www.wikidata.org/entity/Q37973966

about

Burns: an update on current pharmacotherapy Cardiovascular Dysfunction Following Burn Injury: What We Have Learned from Rat and Mouse Models The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat Stress hyperglycemia, insulin treatment, and innate immune cells.Clinical review: Glucose control in severely burned patients - current best practice.Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models Dietary Fructus Schisandrae extracts and fenofibrate regulate the serum/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicity.Fenofibrate does not affect burn-induced hepatic endoplasmic reticulum stress Burns: Pathophysiology of Systemic Complications and Current Management.AMPK-dependent signaling modulates the suppression of invasion and migration by fenofibrate in CAL 27 oral cancer cells through NF-κB pathway.Anticancer Properties of Fenofibrate: A Repurposing Use.

P2860

Q24618730-529AA42D-E63E-4434-ACCE-F6CED5A9112F Q26771250-EB0F151A-3033-4710-990D-D53F919156C5 Q30426929-B71B7427-28DC-46A0-A0E1-0EEC5B28EA43 Q33668059-B1334A11-0EB8-466F-A541-99FA2FC301E6 Q33750033-E61203C4-5348-442E-960C-91371C8CE581 Q33753420-9EBA8748-DAAA-4BF0-85C6-CA2F6CE2A2CA Q36477286-D96EBC9E-9C5B-4C0B-9F4C-131BE3DEC8B5 Q36493910-EA2A3F2C-2360-4EB3-85DF-DA08E86BF60E Q37297015-87D17187-2C7E-4899-91C1-93E1AA027C24 Q37558018-31B3678E-5BF2-4CFE-B199-E2A3C7AE8671 Q38924813-6ED88F0E-C60C-4D73-95F9-29C6A888AA18 Q55021652-922E8AC2-039B-4CBB-A39A-11031F273383

P2860

Role of the PPAR-α agonist fenofibrate in severe pediatric burn.

http://www.wikidata.org/entity/Q37973966

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Role of the PPAR-α agonist fenofibrate in severe pediatric burn.

@en

Role of the PPAR-α agonist fenofibrate in severe pediatric burn.

@nl

type

label

Role of the PPAR-α agonist fenofibrate in severe pediatric burn.

@en

Role of the PPAR-α agonist fenofibrate in severe pediatric burn.

@nl

prefLabel

Role of the PPAR-α agonist fenofibrate in severe pediatric burn.

@en

Role of the PPAR-α agonist fenofibrate in severe pediatric burn.

@nl

P1433

Q37973966-58C2B680-7492-4FC6-994A-503DA2966F72

P1476

Q37973966-C8969996-DC3A-4580-8994-284897DC3D7B

P2093

Q37973966-226BF12B-E22E-4516-9A98-D062A03A14B1

Q37973966-3F6CFA43-9857-4EA0-A6A6-DDC1BD799EC3

Q37973966-5B1ACF37-ED68-4B75-850B-5E2BC343A2B3

Q37973966-6B2DA57C-6759-4167-AD7F-AFF8626C4D9D

Q37973966-889760C6-5F70-47D4-8619-C1B8936ACEA0

Q37973966-D4F30ADE-195A-410B-9A69-B90D85FA8F3F

P2860

Q37973966-0509C30B-C8C1-4591-8D96-516F341A4077

Q37973966-0661FF2F-DCD2-40C8-BB01-7C0BFF3809D9

Q37973966-0A1F55C5-76F0-46EE-A08D-E589D8EACC76

Q37973966-0B6F3540-1E9D-4B67-93B3-66EFC269EBC0

Q37973966-1445AF9A-A291-487D-9878-A573052442D1

Q37973966-20C20B0D-4085-4764-96F0-C99D3158431F

Q37973966-213A61E1-C62C-4461-9A3D-CCA270CED798

Q37973966-216F3531-DF62-4853-B548-EBFA79BAB882

Q37973966-29981D1E-58DC-4728-9253-2FDC83BF6A6D

Q37973966-2A7B44C5-0CAD-4D30-B506-64444D891F81

P304

Q37973966-FF95C132-0429-435B-B3F6-F85CEB3E2619

P31

Q37973966-A8AFF26E-3955-4330-ADC3-C838AA6D3C60

P356

Q37973966-842E896E-3B4F-40D6-B9EF-12A1B971C45E

P433

Q37973966-B97BFB79-90FA-4318-A8E1-1E5B13FFE2A7

P478

Q37973966-C83E3AFE-3DF4-42B4-B652-3C39E894C342

P577

Q37973966-416E4BCD-17C1-4655-998B-4A2B616E8D52

P5875

Q37973966-5FE537D5-C1C0-4D3D-8347-336DD83F25DC

P698

Q37973966-852379B6-5F1D-48A2-A29F-B0375CD80CD8

P932

Q37973966-A67D0A85-1AFE-4211-861E-905F5AFB399D

P356

J.BURNS.2011.12.004

P1433

P1476

Role of the PPAR-α agonist fenofibrate in severe pediatric burn.

@en

P2093

Celeste C Finnerty

http://www.w3.org/2001/XMLSchema#string

David N Herndon

http://www.w3.org/2001/XMLSchema#string

Dirk M Maybauer

http://www.w3.org/2001/XMLSchema#string

Elisabet Børsheim

http://www.w3.org/2001/XMLSchema#string

Itoro E Elijah

http://www.w3.org/2001/XMLSchema#string

Marc O Maybauer

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction

Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

PPARalpha governs glycerol metabolism

Fenofibrate improves insulin sensitivity in connection with intramuscular lipid content, muscle fatty acid-binding protein, and beta-oxidation in skeletal muscle

Cellular mechanisms of insulin resistance

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

Pathophysiologic response to severe burn injury.

Effects of medical therapies on retinopathy progression in type 2 diabetes

Extent and magnitude of catecholamine surge in pediatric burned patients.

P304

481-486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BURNS.2011.12.004

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221730776

http://www.w3.org/2001/XMLSchema#string

P698

22226866

http://www.w3.org/2001/XMLSchema#string

P932

3669757

http://www.w3.org/2001/XMLSchema#string